Abstract
The identification of the TLRs as key sensors of microbial infection has presented a series of new targets for drug development. The TLRs are linked to the most powerful inflammatory pathways in mammals. The question arises from the start: do we wish to stimulate TLR signaling in order to eradicate specific infections and/or neoplastic diseases? Or do we wish to block TLR signaling to treat inflammatory diseases? If we accept that it would be useful to modulate TLR signaling, the next step is to identify the correct molecular target(s) for the task. Perhaps it might even be possible to exercise selectivity, modulating some aspects of TLR signaling and not others. Classical and reverse genetic analyses offer insight into the possibilities that exist, and point to specific checkpoints within signaling pathways at which modulation might normally be imposed.
Keywords: TNF neutralization, sterile inflammation, microbial adjuvants, MyD88-dependent signal transduction, Trif mutation
Current Pharmaceutical Design
Title: TLR Signaling Pathways: Opportunities for Activation and Blockade in Pursuit of Therapy
Volume: 12 Issue: 32
Author(s): K. Hoebe, Z. Jiang, P. Georgel, K. Tabeta, E. Janssen, X. Du and B. Beutler
Affiliation:
Keywords: TNF neutralization, sterile inflammation, microbial adjuvants, MyD88-dependent signal transduction, Trif mutation
Abstract: The identification of the TLRs as key sensors of microbial infection has presented a series of new targets for drug development. The TLRs are linked to the most powerful inflammatory pathways in mammals. The question arises from the start: do we wish to stimulate TLR signaling in order to eradicate specific infections and/or neoplastic diseases? Or do we wish to block TLR signaling to treat inflammatory diseases? If we accept that it would be useful to modulate TLR signaling, the next step is to identify the correct molecular target(s) for the task. Perhaps it might even be possible to exercise selectivity, modulating some aspects of TLR signaling and not others. Classical and reverse genetic analyses offer insight into the possibilities that exist, and point to specific checkpoints within signaling pathways at which modulation might normally be imposed.
Export Options
About this article
Cite this article as:
Hoebe K., Jiang Z., Georgel P., Tabeta K., Janssen E., Du X. and Beutler B., TLR Signaling Pathways: Opportunities for Activation and Blockade in Pursuit of Therapy, Current Pharmaceutical Design 2006; 12 (32) . https://dx.doi.org/10.2174/138161206778743466
DOI https://dx.doi.org/10.2174/138161206778743466 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Use of Natural Compounds as a Potential Therapeutic Agent Against COVID-19
Current Pharmaceutical Design The Effect of Interleukin 38 on Inflammation-induced Corneal Neovascularization
Current Molecular Medicine Ribavirin-Induced Anemia: Mechanisms, Risk Factors and Related Targets for Future Research
Current Medicinal Chemistry Death Due to COVID-19 in an Infant with Combined Immunodeficiencies
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial [Hot-Topic: Optimizing a Therapeutic With Anti-Inflammatory Agents:Novel Drug Delivery Systems (Guest Editor: Carla Martins Lopes)]
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Olive Oil-related Anti-inflammatory Effects on Atherosclerosis: Potential Clinical Implications
Endocrine, Metabolic & Immune Disorders - Drug Targets Redox State in Atrial Fibrillation Pathogenesis and Relevant Therapeutic Approaches
Current Medicinal Chemistry Statins: The Holy Grail of Abdominal Aortic Aneurysm (AAA) Growth Attenuation? A Systematic Review of the Literature
Current Vascular Pharmacology A Comprehensive Review on Phytochemistry and Pharmacological Effects of Stinging Nettle (Urtica dioica)
Current Traditional Medicine Novel Carriers for Controlled Site Specific Delivery of Anti-Inflammatory Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Pathogenic Role of Persistent Milk Signaling in mTORC1- and Milk- MicroRNA-Driven Type 2 Diabetes Mellitus
Current Diabetes Reviews Peroxisome Proliferator-Activated Receptors and the Control of Inflammation
Current Drug Targets - Inflammation & Allergy Glutamatergic Animal Models of Schizophrenia
Current Pharmaceutical Design Tissue Distribution and Pharmacodynamics: A Complicated Relationship
Current Drug Metabolism Calpain-Associated Proteolytic Regulation of the Stromal Microenvironment in Cancer
Current Pharmaceutical Design Increased Exercise Favorably Modifies Coronary Artery Disease and Peripheral Arterial Disease Outcomes
Current Vascular Pharmacology The Association of Collagenase with Human Diseases and its Therapeutic Potential in Overcoming them
Current Biotechnology Oral Tolerance and TGF-β -Producing Cells
Inflammation & Allergy - Drug Targets (Discontinued) Immunological Puzzle Related to Recurrent Miscarriage: Overview
Current Immunology Reviews (Discontinued) Neuroimmune Activation in Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets